MY ACCOUNT | NEWSLETTER |

Effects of bacteriophage supplementation on performance, gut health and blood biochemistry in broilers challenged with necrotic enteritis.

Clinical evidence update from Research in veterinary science


Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for production animal practice, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Research in veterinary science in 2025 evaluated effects of bacteriophage supplementation on performance, gut health and blood biochemistry in broilers challenged with necrotic enteritis..

Key Findings

Necrotic enteritis (NE), primarily caused by Clostridium perfringens (CP) type G, poses a significant threat to broiler health and performance, especially in antibiotic-restricted production systems. Bacteriophage therapy is emerging as a promising alternative to antibiotics for controlling enteric pathogens in poultry, including CP. However, a critical knowledge gap exists in specifically determining the in vivo effects of bacteriophages combined with probiotics against CP strains associated with NE in broilers under practical conditions. Therefore, this study aimed to evaluate the efficacy of a bacteriophage preparation (PathoGone™-DWA;...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for production animal practice.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

How one rescue dog found new life in a rehab clinic at the Veterinary Teaching Hospital

Like0
Dislike0

Our Chief Medical Officer

Like0
Dislike0

Evaluation of neutrophillymphocyte and plateletneutrophil ratios and their prognostic utility in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism.

Like0
Dislike0

Therapeutic Outcomes and Owner Assessment in Canine Sebaceous Adenitis Across Breeds A Multicentre Retrospective Analysis and Owner Survey.

Like0
Dislike0

The Lundquist Institute Launches the Nation's First Adult Exercise Medicine Fellowship

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top